There were 1,030 press releases posted in the last 24 hours and 190,602 in the last 365 days.

Global Ablation Devices Market Is Expected to Reach USD 32.45 billion by 2027 : Fior Markets

Ablation Devices Market by Technology (Electrical, Radiation, Radiofrequency, Light, Ultrasound, Cryotherapy, Thermal, Microwave, Hydromechanical), Product (Disposable, Capital, Reusable), Application (Oncology, Cardiology, Ophthalmology, Pain Management, Gynaecology, Urology, Orthopaedic Treatment, Cosmetic Surgery), End-User (Hospitals, Ambulatory Surgical Centers, Others), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027

/EIN News/ -- Newark, NJ, Oct. 12, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global ablation devices market is expected to grow from USD 14.39 billion in 2019 and to reach USD 32.45 billion by 2027, growing at a CAGR of 10.7% during the forecast period 2020-2027.

The global ablation devices market is witnessing significant growth from the recent years. This growth is attributed to the rising prevalence of chronic pain disorders like osteoporosis, arthritis, improving healthcare infrastructure, growing geriatric population, and rising life expectancy. The minimally invasive procedure is less painful than conventional surgical procedures and will propel the market growth. Technological advancements, short duration and high efficacy of the procedures are the other major factors influencing the market growth.

Ablation is defined as the destruction of material from an object by chipping, vaporization, or other erosive processes. The process uses radiofrequency energy to destroy a small heart tissue area that is causing irregular and rapid heartbeats. The ablation devices offer a minimally invasive alternative to traditional surgical treatment of prostate, liver, kidney, and lung cancer. It is a less painful procedure than conventional surgical operations. 

The global ablation devices market is expected to witness significant growth, owing to the increasing adoption of minimally invasive procedures, increasing cases of cancer and cardiovascular disorders, and growing pain management and cosmetic surgery cases. The factors restraining the market growth are the high cost incurred with these devices, lack of advanced and innovative technologies to treat cancer, and risk associated with ablation procedures. Untapped markets in developing economies and rising awareness will provide market growth opportunities.

DOWNLOAD FREE SAMPLE REPORT AT https://www.fiormarkets.com/report-detail/418952/request-sample

The key players operating in the global ablation device market are Abbott Laboratories, Atricure, Boston Scientific, Medtronic Plc, Biosense Webster, Alcon Laboratories, Johnson and Johnson, CONMED, Varian, Angiodynamics, and Elekta AB. To gain a significant market share in the global ablation devices market, the key players are now focusing on adopting strategies such as product innovations, mergers & acquisitions, recent developments, joint venture, collaborations, and partnership. Abbott Laboratories and Medtronic Plc are some of the key manufacturers operating in ablation devices.

  • For instance, in November 2016, HAT500 radiofrequency ablation system in Europe was launched by OSYPKA AG. This radiofrequency ablation system is used for the treatment of ventricular tachycardias.
  • In July 2017, Cosman Medical Inc., a manufacturer of RF ablation systems, was acquired by Boston Scientific Corporation. This acquisition will help in expanding Boston Scientific’s portfolio with systems like Deep Brain Stimulation Systems and Spinal Cord Stimulator.

Radiofrequency ablation technology segment dominated the market and held the largest market share of 20.35% in the year 2019
On the basis of technology, the global ablation devices market is segmented into electrical, radiation, radiofrequency, light, ultrasound, cryotherapy, thermal, microwave, and hydromechanical. The electrical technology is segmented into electrical ablators, argon plasma/ beam coagulator, irreversible electroporation, and electronic brachytherapy. The radiation technology is segmented into brachytherapy, high-dose-rate brachytherapy, pulsed-dose-rate brachytherapy, stereotactic radiotherapy and radiosurgery, image-guided radiation therapy, intensity-molded radiation therapy, stereotactic body radiation therapy, and proton beam therapy. The light technology is segmented into cold laser and excimer laser. The ultrasound technology is segmented into high-intensity focused ultrasound, magnetic resonance imaging-guided focus ultrasound (MRI-FUS), ultrasound surgical systems, and shock wave lithotripsy. The cryotherapy technology segment is segmented into tissue contact probe, cryogen spray probe, and epidermal and subcutaneous cryoablation devices. Radiofrequency Ablation Technology segment dominated the market and held the largest market share of 20.35% in the year 2019. This growth was attributed to the increased demand for radiofrequency ablation devices and rise in the geriatric population.

Disposable product segment dominated the market and held the largest market share of 38.2% in the year 2019
On the basis of product, the global ablation devices market is segmented into disposable, capital, and reusable. Disposable product segment dominated the market and held the largest market share of 38.2% in the year 2019. This growth was attributed to the low cost and increasing demand from end-users for ablation procedures. The reusable segment is anticipated to witness significant growth due to lower costs and a reduction in medical waste associated with reusable ablation devices.

Browse full report with TOC at https://www.fiormarkets.com/report/ablation-devices-market-by-technology-electrical-radiation-radiofrequency-418952.html

Pain management segment dominated the market and held the largest share of 21.8% in the year 2019
On the basis of application, the global ablation devices market is segmented into oncology, cardiology, ophthalmology, pain management, gynecology, urology, orthopedic treatment, and cosmetic surgery. The pain management segment dominated the market and held the largest share of 21.8% in the year 2019. This growth was because  it is a minimally invasive procedure, where the nerve fibers carrying signals to the brain are destroyed to stop the pain. Oncology segment is anticipated to witness significant growth, owing to the better potential benefits of oncology ablation devices compared to other medical treatments of chronic disorders like cancer. 

Hospitals segment dominated the market and held the largest share of 37.6% in the year 2019
On the basis of end-user, the global ablation devices market is segmented into hospitals, ambulatory surgical centers, and others. Hospitals segment dominated the market and held the largest share of 37.6% in the year 2019. This growth was attributed to the greater budget and a large number of ablation procedures that take place in these settings. The ambulatory surgical centers are anticipated to witness significant growth, owing to patients' rising preferences towards ambulatory surgical centers.

Regional Segment of Ablation Devices Market

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and Rest of South America)
  • Middle East and Africa (UAE, South Africa, Rest of MEA)

Request for Customization: https://www.fiormarkets.com/enquiry/request-customization/418952

On the basis of geography, the global ablation devices market is classified into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America held the major share of 26.19% in the year 2019. This growth was attributed to the increasing launches of ablation devices. In the region, the U.S. holds the largest share, owing to the rising prevalence of cancer, the growing influence of minimally invasive medical devices, high disposable income and various reimbursement policies. The Asia-Pacific region market is projected to witness significant growth, owing to the increasing prevalence of cancer in the region. 

About the report:

The global ablation devices market is analysed on the basis of value (USD billion). All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insights of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitors’ position grid analysis.

For Instant Purchase: https://www.fiormarkets.com/checkout.html?reportid=418952&type=single

Customization of the Report:

The report can be customized as per client requirements. For further queries, you can contact us at sales@fiormarkets.com or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

About Fior Markets

Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients’ objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. Fior Markets deploys a wide range of regional and global market intelligence research reports including industries like technology, pharmaceutical, consumer goods, food and beverages, chemicals, media, materials and many others. Our Strategic Intelligence capabilities are purposely planned to boost your business extension and elucidate the vigor of diverse industry. We hold distinguished units of highly expert analysts and consultants according to their respective domains. The global market research reports we provide involve both qualitative and quantitative analysis of current market scenario as per the geographical regions segregated and comprehensive performance in different regions with global approach. In addition, our syndicated research reports offer a packaged guide to keep companies abreast of the upcoming major restyle in their domains. Fior Markets facilitates clients with research analysis that are customized to their exact requirements, specifications and challenges, whether it is comprehensive desk research, survey work, composition of multiple methods, in-detailed interviewing or competitive intelligence. Our research experts are experienced in matching the exact personnel and methodology to your business need.

Contact Us

Avinash D
Head of Business Development
Phone: +1-201-465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com






To Know More Market Research Reports and Industry Analysis, Visit our Associate Website: https://marketandresearch.biz

Related Reports
Endocrine Testing Market - https://www.fiormarkets.com/report/endocrine-testing-market-by-technology-immunoassay-tandem-mass-418823.html
Epigenetics Drugs & Diagnostic Technologies Market - https://www.fiormarkets.com/report/epigenetics-drugs-diagnostic-technologies-market-by-product-418825.html
Healthcare Supply Chain BPO Market - https://www.fiormarkets.com/report/healthcare-supply-chain-bpo-market-by-payer-service-418827.html
Lentiviral Vectors Market - https://www.fiormarkets.com/report/lentiviral-vectors-market-by-disease-infectious-diseases-genetic-418828.html

Primary Logo